Generate a tailored SOP for Dr. Markus Müschen. Improve your application with a focused, well-structured draft.
Markus Müschen, MD-PhD, is the Director of the Center of Molecular and Cellular Oncology, Arthur H. Isabel Bunker Professor of Hematology, and Professor of Immunobiology at Yale University. He serves as Chief of the Division of Basic Science at the Yale Cancer Center. His research program focuses on signal transduction mechanisms in lymphoid malignancies, particularly in drug-resistant leukemia and lymphoma. His laboratory has established new conceptual frameworks for understanding B-cell signaling and energy metabolism mechanisms altered in lymphoid malignancies. Müschen studied medicine at Heinrich-Heine-Universität Düsseldorf, Germany, Université de Nantes in France, and the Institut Pasteur in Paris, France. He completed clinical training in hematology-oncology at the University of Cologne and has held postdoctoral fellowships in immunology and leukemia genetics. Before joining Yale, Müschen was a full professor at the University of California, San Francisco, where he led the Hematological Malignancies Program at the UCSF Comprehensive Cancer Center. Müschen is currently a Howard Hughes Medical Institute Faculty Scholar and an elected member of the American Society for Clinical Investigation and the Connecticut Academy of Science.
Center of Molecular and Cellular Oncology • Yale University
Leading the research and operational activities of the oncology center.
Yale University • New Haven, CT
Teaching and conducting research in the field of medical oncology and hematology.
Administered via the Graduate School of Arts and Sciences (GSAS). GRE General is optional for PhD.